These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A novelty-related sustained elevation of vasopressin plasma levels in young men is not associated with an enhanced response of adrenocorticotropic hormone (ACTH) to human corticotropin releasing factor (hCRF). Ehrenreich H, Stender N, Gefeller O, tom Dieck K, Schilling L, Kaw S. Res Exp Med (Berl); 1996; 196(5):291-9. PubMed ID: 9010961 [Abstract] [Full Text] [Related]
10. The association of age with plasma arginine vasopressin and plasma osmolality. Duggan J, Kilfeather S, Lightman SL, O'Malley K. Age Ageing; 1993 Sep; 22(5):332-6. PubMed ID: 8237622 [Abstract] [Full Text] [Related]
12. Circadian variation of plasma arginine vasopressin concentration, or arginine vasopressin in enuresis. Aikawa T, Kasahara T, Uchiyama M. Scand J Urol Nephrol Suppl; 1999 Sep; 202():47-9. PubMed ID: 10573793 [Abstract] [Full Text] [Related]
13. A synergistic adrenocorticotropin response to naloxone and vasopressin in normal humans: evidence that naloxone stimulates endogenous corticotropin-releasing hormone. Hockings GI, Grice JE, Walters MM, Crosbie GV, Torpy DJ, Jackson RV. Neuroendocrinology; 1995 Feb; 61(2):198-206. PubMed ID: 7753339 [Abstract] [Full Text] [Related]
18. Safety, tolerability, and pharmacokinetics of SR 49059, a V1a vasopressin receptor antagonist, after repeated oral administration in healthy volunteers. Brouard R, Laporte V, Serradeil Le Gal C, Pignol R, Jang H, Donat F, Lockwood G, Fournie D, Dreux F. Adv Exp Med Biol; 1998 Oct; 449():455-65. PubMed ID: 10026839 [Abstract] [Full Text] [Related]
19. The luteinizing hormone but not the cortisol response to arginine vasopressin is prevented by naloxone and a corticotropin-releasing hormone antagonist in the ovariectomized rhesus monkey. Xiao E, Xia-Zhang L, Thornell D, Shalts E, Ferin M. Neuroendocrinology; 1996 Sep; 64(3):225-32. PubMed ID: 8875440 [Abstract] [Full Text] [Related]
20. Effect of corticotrophin-releasing hormone on arginine vasopressin and atrial natriuretic factor in patients with Cushing's disease. Colao A, Pivonello R, Ferone D, Faggiano A, Facciolli G, Di Somma C, Boudouresque F, Oliver C, Lombardi G. Clin Endocrinol (Oxf); 1998 Jul; 49(1):77-84. PubMed ID: 9797850 [Abstract] [Full Text] [Related] Page: [Next] [New Search]